Loading...
•
Sep 30, 2021
10X Genomics Q3 2021 Earnings Report
Reported a strong third quarter with revenue growth and successful product launches.
Key Takeaways
10x Genomics reported a 74% increase in revenue compared to the same quarter last year, reaching $125.3 million. The company launched the Chromium X instrument and saw customer publications surpass 3,000 research papers. Despite the strong revenue growth, the company reported an operating loss of $15.9 million.
Revenue was $125.3 million, a 74% increase year-over-year.
Launched the Chromium X instrument.
Customer publications surpassed 3,000 research papers.
Operating loss was $15.9 million.
Forward Guidance
10x Genomics revised its full year 2021 revenue guidance to $490 million to $500 million, representing 64% to 67% growth over full year 2020 revenue.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...